On the Record · Exelixis
Exelixis acquisitions, on the record
The businesses Exelixis bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
Iconic (rights to anti-TF antibodies)Word for word“In January 2022, we announced an amendment to our agreement with Iconic, which we entered into in December 2021, to acquire broad rights to use the anti-TF antibody used in XB002 for any application, including conjugated to other payloads, as well as rights within oncology to a number of other anti-TF antibodies developed by Iconic, including for use in ADCs and multispecific biotherapeutics.” 10-K for 2023 | acquisition | January 2022 | — |
Basecamp Bio Inc.Word for word“In August 2025, we entered into an asset purchase agreement with Basecamp Bio Inc. (Basecamp Bio), under which we acquired all right, title and interest in Basecamp Bio’s program directed at SSTR2, an oncology target that is highly expressed in NET.” 10-K for 2026 | acquisition | August 2025 | — |
Deal filings since 2016
- 2019-12-19 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2019-04-05 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-07-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-05-02 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-02-27 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-01-31 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-12-21 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-08-22 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-08-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Exelixis’s annual reports (10-K for 2026, 10-K for 2025, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-10. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.